Mannheim

• A Phase 2 Parallel Group Study in Adults with Type 2 Diabetes to evaluate Efficacy and Safety of GL0034 Ended
  2024-513279-41-00 4 2024-09-06 Type 2 diabetes mellitus
• CABONEN – a phase II trial of Cabozantinib in patients with advanced, low proliferative NEN G3 Ended
  2024-510863-50-00 4 2024-08-30 Neuroendocrine Neoplasia Neuroendocrine Tumor
• A study to learn about the safety of BAY 3283142 in people with mild to moderate high blood pressure Ended
  2024-512060-58-00 3 2024-08-07 Chronic kidney disease
• A randomized, single-center, double-blind, placebo-controlled, first-in-human trial with single and multiple ascending doses to determine sa … Ended
  2024-512510-17-00 1 2024-08-05 Treatment of pain
• A Double-blind, Placebo-controlled, Phase IIb, Multi-center, Twelve-week Prospective Study to Evaluate the Efficacy and Safety of Gemlapodec … Ended
  2023-505086-83-00 4 2024-07-10 Tourette Syndrome
• A study to learn about the taste of Vericiguat given in liquid form in healthy male participants aged 18 to 45 years Ended
  2023-508447-52-00 3 2024-06-28 Heart failure in children
• A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering … Ended
  2024-511076-32-00 6 2024-06-21 Hypercholesterolemia
• A study in healthy people to compare how 2 different low dose formulations of BI 1015550 are taken up in the body Ended
  2023-509951-15-00 2 2024-06-06 Pharmacokinetic trial
• A study to test how BI 456906 is taken up in the blood of people with and without kidney problems Ended
  2023-508557-13-00 3 2024-05-08 Renal impairment (mild, moderate and severe)
• A study in healthy people to see how zongertinib is taken up into the blood when given as tablets made by two different manufacturers Ended
  2023-510495-31-00 2 2024-04-24 Healthy volunteer trial
• A phase Ib/II single-arm, multicenter study of sacituzumab-govitecan, a TROP-2 targeting antibody linked with SN38, for patients with metast … Ended
  2023-505257-40-00 9 2024-04-17 metastatic esophagogastric adenocarcinoma (Stage IV)
• Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis Ended
  2023-510127-30-00 1 2024-04-17 Relapsing Remitting Multiple Sclerosis (RRMS)
• Bioequivalence study of the oral suspension of netupitant/palonosetron combination product versus the hard capsules of netupitant/palonosetr … Ended
  2023-504355-28-03 2 2024-03-14 Healthy volunteers
• A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control W … Ended
  2023-507206-13-00 5 2024-03-14 Type 2 Diabetes
• A Trial to Investigate TransCon TLR7/8 Agonist in Combination with Pembrolizumab, TransCon TLR7/8 Agonist in Combination with TransCon IL-2 … Ended
  2023-506092-10-00 4 2024-03-11 Stage III-IVA Resectable Locoregionall Advanced Head and Neck Squamous
• A study to learn if baxdrostat works at reducing blood pressure and is safe in people with high blood pressure Ended
  2023-505499-32-00 5 2024-03-08 Uncontrolled hypertension (uTHN) defined as blood pressure that remain
• A six-way relative bioavailability study comparing 10, 30, 40 and 50 mg leniolisib film coated tablets and 30 mg film coated granules with 7 … Ended
  2023-508880-61-00 3 2024-03-06 Activated Phosphoinositide 3-Kinase Delta Syndrome
• A study to test whether multiple doses of BI 456906 have an effect on cardiac safety in people with overweight or obesity. Ended
  2023-506375-10-00 3 2024-03-04 Healthy volunteer trial
• An open-label cocktail drug-drug interaction (DDI) clinical study to assess the effect of multiple oral dosing with leniolisib on the pharma … Ended
  2023-507134-25-00 3 2024-01-29 Activated Phosphoinositide 3-Kinase Delta Syndrome
• A study in healthy people to test whether iclepertin has an effect on cardiac safety Ended
  2023-504693-38-00 3 2024-01-25 Healthy
• A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended
  2022-501418-69-00 5 2023-11-21 Acute Coronary Syndrome
• Safety, tolerability, and efficacy of ACOU085 for prevention of hearing loss in testicular cancer patients receiving cisplatin Ended
  2023-503696-15-00 4 2023-11-10 sensorineural hearing loss (SNHL)
• A Phase 3b, Open-label Study to Evaluate the Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-S … Ended
  2023-505558-16-00 5 2023-10-24 Atopic Dermatitis
• A study in healthy men to test whether carbamazepine influences the amount of BI 1810631 in the blood Ended
  2022-503046-50-00 3 2023-09-11 Healthy volunteer trial

Showing 289–312 of 361 trials